TWD
EWTX icon

True Wealth Design’s Edgewise Therapeutics EWTX Stock Holding History

True Wealth Design’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$163 Buy
+4
New +$170 ﹤0.01% 2379

Other funds holding EWTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.68B AUM 19.3% 1-Year Est. Return

True Wealth Design's EWTX Position: Q3 2026 in Review

True Wealth Design opened a new position in Edgewise Therapeutics (EWTX) in Q3 2026: 4 shares worth $163. The stake represents ﹤0.01% of the portfolio and ranks #2379 among its holdings.

9 funds tracked by Wall St. Rank hold EWTX as of Q3 2026.

  • True Wealth Design held 4 shares of Edgewise Therapeutics worth $163 as of Q3 2026.
  • Edgewise Therapeutics was a new True Wealth Design position in Q3 2026.
  • Edgewise Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #2379 holding.
  • 9 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.